4 reports

  • Executive Summary
  • 4.3 Molecular Targets in the Pipeline

Gastrointestinal morbidity in obesity.

  • Clinical Trial
  • Gastrointestinal Drug
  • Pharmaceutical
  • Market Size
  • Johnson & Johnson

Offers a wide range of drugs and pharmaceuticals for the treatment of neuroscience and gastrointestinal diseases.

  • Gastrointestinal Drug
  • World
  • Forecast
  • Market Size
  • Johnson & Johnson
  • Gastrointestinal Drugs
  • MARKET AND COMPETITIVE ANALYSIS
  • Allergy Drug
  • Gastrointestinal Drug
  • OTC
  • United States
  • Johnson & Johnson

The gut is especially vulnerable to tension and can demonstrate stress-induced physiological changes causing gastrointestinal discomfort.

  • Gastrointestinal Drug
  • OTC
  • Retail
  • Johnson & Johnson
  • Sanofi S.A.